RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 163 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $31,000 | +3.3% | 26,693 | 0.0% | 0.00% | – |
Q2 2022 | $30,000 | -62.5% | 26,693 | 0.0% | 0.00% | – |
Q1 2022 | $80,000 | -29.2% | 26,693 | -37.1% | 0.00% | -100.0% |
Q4 2021 | $113,000 | -29.4% | 42,462 | -3.6% | 0.00% | 0.0% |
Q3 2021 | $160,000 | -15.3% | 44,051 | +1.2% | 0.00% | 0.0% |
Q2 2021 | $189,000 | +56.2% | 43,540 | +23.4% | 0.00% | 0.0% |
Q1 2021 | $121,000 | -32.8% | 35,279 | -31.6% | 0.00% | 0.0% |
Q4 2020 | $180,000 | +682.6% | 51,548 | +427.2% | 0.00% | – |
Q3 2020 | $23,000 | +27.8% | 9,778 | 0.0% | 0.00% | – |
Q2 2020 | $18,000 | +20.0% | 9,778 | 0.0% | 0.00% | – |
Q1 2020 | $15,000 | -28.6% | 9,778 | 0.0% | 0.00% | – |
Q4 2019 | $21,000 | +16.7% | 9,778 | 0.0% | 0.00% | – |
Q3 2019 | $18,000 | -30.8% | 9,778 | 0.0% | 0.00% | – |
Q2 2019 | $26,000 | +4.0% | 9,778 | 0.0% | 0.00% | – |
Q1 2019 | $25,000 | -41.9% | 9,778 | -47.7% | 0.00% | – |
Q4 2018 | $43,000 | -28.3% | 18,695 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $60,000 | +66.7% | 18,695 | +47.8% | 0.00% | – |
Q2 2018 | $36,000 | – | 12,653 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |